A.E. Friedland, et al. Staphyloccocus aureus Cas9: An alternative Cas9 for genome editing applications. Presented at Keystone Symposium for Precision Genome Engineering and Synthetic Biology, January 12, 2015.

May

2

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

May

1

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Apr

22

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting